Pharma giant Jazz dismisses final patent claim involving cannabinoid epilepsy drug
Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.
News February 11
Latest In: Jazz Pharmaceuticals
Lawsuit: Generic drugmakers infringed on Epidiolex cannabis drug patents
Global pharma giant Jazz Pharmaceuticals filed a lawsuit alleging that a list of generic drug companies infringed on…
News January 9
Court tosses Canopy cannabis patent infringement lawsuit against GW Pharma
A Texas court has dismissed a lawsuit brought by Canadian cannabis producer Canopy Growth against GW Pharmaceuticals, although…
News March 2
Sponsored
Green Life Business Group brokers the cannabis industry’s biggest deals
The best time to get into the cannabis industry is now.
June 22
How will inflation impact cannabis retail + two deals that illustrate industry change
While wholesale cannabis prices have been going up - sometimes as much as 30%, according to a recent…
News December 22
Intellectual property takes on growing role in cannabis industry deals
Intellectual property is playing an increasingly important role in cannabis industry acquisitions and other deals as businesses look…
News April 5
Medical cannabinoid firm GW Pharma to be acquired by Jazz Pharmaceuticals for $7.2 billion
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest…
News February 3Featured
1
Latest Sponsored
